Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?

Recent studies indicate that cancer antigen 125 (CA125) response criteria tend to overestimate a tumour reduction measured by standard WHO response criteria in recurrent epithelial ovarian carcinoma. The aim of the study was to validate the recently introduced GCIG (The Gynaecological Cancer Intergr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gronlund, B, Hansen, H H, Høgdall, C, Høgdall, E V S, Engelholm, S A
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2004
Matèries:
Clinical
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409573/
https://ncbi.nlm.nih.gov/pubmed/14735180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601501
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars